C. Di Cresce

siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine

J. Koropatnick, C. Di Cresce, R. Figueredo, 2015, Oncotarget.

IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells

Di Chen, J. Koropatnick, Xiufen Zheng, 2015, PloS one.

BRCA2 inhibition enhances cisplatin‐mediated alterations in tumor cell proliferation, metabolism, and metastasis

K. Baggerly, A. Sood, A. Chambers, 2014, Molecular oncology.

Regional localization within the bone marrow influences the functional capacity of human HSCs.

C. Di Cresce, M. Bhatia, Zoya Shapovalova, 2013, Cell stem cell.

Combining Small Interfering RNAs Targeting Thymidylate Synthase and Thymidine Kinase 1 or 2 Sensitizes Human Tumor Cells to 5-Fluorodeoxyuridine and Pemetrexed

J. Koropatnick, C. Di Cresce, R. Figueredo, 2011, Journal of Pharmacology and Experimental Therapeutics.

Antisense treatment in human prostate cancer and melanoma.

J. Koropatnick, C. Di Cresce, 2010, Current cancer drug targets.